SRTA
Strata Critical Medical, Inc.
$5.94
+0.15
(+2.59%)
Mkt Cap
513.97M
Volume
1,351,031
52W Range
3.85-6.5
Sector
Healthcare
Beta
2.25
EPS (TTM)
0.50 USD
P/E Ratio
11.90
Revenue (TTM)
255.97M USD
Rev Growth (5Y)
+50.0%
EPS Growth (5Y)
N/A
AlphaVal · Fair Value
What we estimate one share is worth
$11.23
Undervalued
strong signal
47.1% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Stable Earnings Power
30.0 / 100 pillar composite (overridden)
Steady, predictable earnings power — graded A–F vs. similar companies.
Company Description
Strata Critical Medical, Inc. is dedicated to supporting healthcare providers throughout the United States by offering swift logistical management and specialized medical assistance. A significant part of their operations involves the movement of human organs for transplant, utilizing both aerial and ground transportation methods. Founded in 2014, the organization previously operated under the name Blade Air Mobility, Inc. and is set to officially change its name to Strata Critical Medical, Inc. in August of 2025. Its primary corporate office is located in New York, New York.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 197.14M | 248.69M | 225.18M | 146.12M | 50.53M | 23.43M | 31.20M |
| Net Income | 41.35M | (27.31M) | (56.08M) | (27.26M) | (40.05M) | (10.16M) | (10.84M) |
| EPS | 0.50 | -0.35 | -0.76 | -0.38 | -0.57 | -0.81 | -1.47 |
| Free Cash Flow | (59.92M) | (35.51M) | (34.46M) | (37.86M) | (16.42M) | (11.20M) | (11.16M) |
| FCF / Share | -0.73 | -0.46 | -0.47 | -0.53 | -0.23 | -0.89 | -1.52 |
| Operating CF | (48.91M) | (2.52M) | (32.35M) | (37.13M) | (15.62M) | (10.82M) | (10.30M) |
| Total Assets | 325.47M | 256.68M | 294.94M | 325.02M | 335.88M | 17.71M | 277.69M |
| Total Debt | 3.31M | 9.32M | 24.52M | 18.33M | 716,000 | 1.89M | 462,732 |
| Cash & Equiv | 30.97M | 18.38M | 27.87M | 41.34M | 2.60M | 12.16M | 1.31M |
| Book Value | 279.07M | 221.94M | 234.30M | 274.49M | 291.37M | 11.08M | 5.00M |
| Return on Equity | 0.15 | -0.12 | -0.24 | -0.10 | -0.14 | -0.92 | -2.17 |
| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 72.51M | 67.38M | 66.79M | 49.30M | 70.80M | 54.31M | 54.36M | 74.88M | 67.94M | 51.51M | 47.48M | 71.44M |
| Net Income | (10.52M) | 2.15M | (8.83M) | 57.42M | (3.74M) | (3.49M) | (9.79M) | (1.95M) | (11.33M) | (4.23M) | (33.94M) | 289,000 |
| EPS | -0.12 | 0.03 | -0.11 | 0.70 | -0.05 | -0.04 | -0.12 | -0.03 | -0.15 | -0.06 | -0.45 | 0.00 |
| Free Cash Flow | 3.83M | (1.93M) | (10.31M) | (34.97M) | (5.80M) | (3.39M) | (5.03M) | (3.56M) | (9.46M) | (16.71M) | (9.34M) | 1.31M |
| FCF / Share | 0.04 | -0.02 | -0.13 | -0.42 | -0.07 | -0.04 | -0.06 | -0.05 | -0.12 | -0.22 | -0.13 | 0.02 |
| Operating CF | 6.02M | 3.56M | (8.31M) | (31.84M) | (3.06M) | (246,000) | 13,000 | 6.36M | 7.44M | (15.59M) | (9.32M) | 2.01M |
| Total Assets | 332.70M | 327.62M | 325.47M | 335.08M | 257.92M | 250.55M | 256.68M | 282.94M | 280.33M | 282.79M | 294.94M | 317.51M |
| Total Debt | 4.25M | 4.47M | 3.31M | 3.47M | 8.84M | 9.07M | 9.32M | 23.74M | 22.01M | 25.53M | 24.52M | 24.35M |
| Cash & Equiv | 16.32M | 58.72M | 30.97M | 22.75M | 58.75M | 34.83M | 18.38M | 20.03M | 26.31M | 36.76M | 27.87M | 36.81M |
| Book Value | 279.32M | 285.73M | 279.07M | 283.00M | 223.10M | 219.73M | 221.94M | 233.50M | 229.39M | 236.61M | 234.30M | 262.88M |
| Return on Equity | -0.04 | 0.01 | -0.03 | 0.20 | -0.02 | -0.02 | -0.04 | -0.01 | -0.05 | -0.02 | -0.14 | 0.00 |
SRTA News
Can Strata Critical Medical, Inc. (SRTA) Run Higher on Rising Earnings Estimates?
Wall Street Analysts Predict a 60% Upside in Strata Critical Medical, Inc. (SRTA): Here's What You Should Know
Strata Critical Medical, Inc. (SRTA) Q2 2026 Earnings Call Transcript
Strata Critical Medical Announces Second Quarter 2026 Results
Strata Critical Medical Schedules Second Quarter 2026 Earnings Conference Call
Strata Critical Medical: A Better Alternative To TransMedics In Organ Transplant Logistics
Strata Acquires Heart and Lung Transplant National Recovery Program, Expanding National Organ Recovery Platform
Strata Critical Medical, Inc. (SRTA) Surges 8.5%: Is This an Indication of Further Gains?
Strata Acquires Louisville Perfusion Services
AIAI Holdings Corporation Announces Appointment of Board of Directors